Grupo Juste SAQF:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Grupo Juste SAQF - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3299
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Grupo Juste SAQF (Juste) is a developer and distributor of proprietary medicines and active pharmaceutical ingredients. The company offers oral and injectable radiological contrast media; diatrizoic acid, iothalamic acid, iohexol, iopamidol, iodixanol, MRI contrast agents, dihexazin, and others. Its services include custom manufacturing, accelerated stability studies and research and development. Juste offers products in the therapeutic areas of central nervous system, women’s health, radiology and primary care, among others. Juste works in collaboration with pharmaceutical companies and health professionals. The company has its operations in Europe, Asia, the Middle East, Australia, Africa and Central and South Americas. Juste is headquartered in Coslada, Spain.

Grupo Juste SAQF – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Grupo Juste SAQF, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Grupo Juste SAQF, Medical Devices Deals, 2012 to YTD 2018 9
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Grupo Juste Enters into Licensing Agreement with RedHill Biopharma and IntelGenx 11
D&A Pharma Enters into Licensing Agreement with Grupo JUSTE 12
Asset Transactions 13
Exeltis Acquires Juste Farma Division from Juste labs 13
Grupo Juste SAQF – Key Competitors 14
Grupo Juste SAQF – Key Employees 15
Grupo Juste SAQF – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Key Facts 2
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Grupo Juste SAQF, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Grupo Juste SAQF, Deals By Therapy Area, 2012 to YTD 2018 8
Grupo Juste SAQF, Medical Devices Deals, 2012 to YTD 2018 9
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Grupo Juste Enters into Licensing Agreement with RedHill Biopharma and IntelGenx 11
D&A Pharma Enters into Licensing Agreement with Grupo JUSTE 12
Exeltis Acquires Juste Farma Division from Juste labs 13
Grupo Juste SAQF, Key Competitors 14
Grupo Juste SAQF, Key Employees 15
Grupo Juste SAQF, Subsidiaries 16

List of Figures
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Grupo Juste SAQF, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Grupo Juste SAQF, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Grupo Juste SAQF:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Galp Energia SGPS SA (GALP)-石油・ガス分野:企業M&A・提携分析
    Summary Galp Energia SGPS S.A. (Galp Energia) is an integrated oil and natural gas company. It explores for, develops and produces crude oil and natural gas; refines crude oil and markets refined petroleum products. The company also imports, transports and distributes natural gas. It conducts the na …
  • Capital City Bank Group Inc:企業の戦略・SWOT・財務分析
    Capital City Bank Group Inc - Strategy, SWOT and Corporate Finance Report Summary Capital City Bank Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Valneva SE:企業のM&A・事業提携・投資動向
    Valneva SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Valneva SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • The Nature’s Bounty Co:企業の戦略的SWOT分析
    The Nature's Bounty Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • OPKO Health Inc (OPK):医療機器:M&Aディール及び事業提携情報
    Summary OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vac …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • INRange Systems Inc-医療機器分野:企業M&A・提携分析
    Summary INRange Systems Inc (INRange) is a medical device company that develops and markets remote management systems for the healthcare sector. The company provides remote medication management system to improve adherence to medication therapy by remotely managing, storing, delivering, and monitori …
  • Kaiser Foundation Health Plan of Washington:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan of Washington - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Stryker Corp (SYK):医療機器:M&Aディール及び事業提携情報
    Summary Stryker Corp (Stryker) is a medical technology company that manufactures an array of orthopaedic, medical and surgical, and neurotechnology and spine products and allied services. Its major products include orthopaedic implants; surgical equipment and surgical navigation systems; patient han …
  • Public Gas Corporation SA:企業の戦略的SWOT分析
    Public Gas Corporation SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • iBio Inc (IBIO)-製薬・医療分野:企業M&A・提携分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It uses its ibiolaunch platform, which is a transformative technology for the production of monoclonal antibodies, …
  • Graftobian Makeup Company:企業の戦略・SWOT・財務情報
    Graftobian Makeup Company - Strategy, SWOT and Corporate Finance Report Summary Graftobian Makeup Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Heptares Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Heptares Therapeutics Ltd (Heptares), a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise …
  • Latvenergo AS:企業の戦略的SWOT分析
    Latvenergo AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Tulmar Safety Systems Inc.:企業の戦略・SWOT・財務分析
    Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report Summary Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Valmont Industries Inc (VMI):企業の財務・戦略的SWOT分析
    Valmont Industries Inc (VMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Shanghai Electric Group Co Ltd:企業のM&A・事業提携・投資動向
    Shanghai Electric Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shanghai Electric Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • AC Immune SA (ACIU):医療機器:M&Aディール及び事業提携情報
    Summary AC Immune SA (AC Immune) is a biopharmaceutical company that develops products for treating neurodegenerative diseases. It discovers, designs and develops innovative proprietary medicines to prevent, diagnose and treat neurodegenerative diseases associated with protein misfolding. The compan …
  • BioMoti Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary BioMoti Ltd (BioMoti) is a pharmaceutical company that offers cancer therapeutics that develops platform drug delivery technologies. The company provides products such as Oncojans a class of immunotherapeutic drug-loaded particles to target and gain entry into the tumour vasculature and canc …
  • Graham Holdings Company (GHC):企業の財務・戦略的SWOT分析
    Graham Holdings Company (GHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆